SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Identification of biomarkers associated with inflammatory response in Parkinson's disease by bioinformatics and machine learning.

PLoS One · 2025-05-28

DOI: 10.1371/journal.pone.0320257PMID: 40435035

Open accessResearch Support, Non-U.S. Gov't; research-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Parkinson's disease (PD) is a common and debilitating neurodegenerative disorder. The inflammatory response is essential in the pathogenesis and progression of PD. The goal of this study is to combine bioinformatics and machine learning to screen for biomarker genes related to the inflammatory response in PD. First, differentially expressed genes associated with inflammatory response were screened, PPI networks were constructed and enriched for analysis. LASSO, SVM-RFE and Random Forest algorithms were used to screen biomarker genes. Then, ROC curves were drawn and PD risk predicting models were constructed on the basis of the biomarker genes. Finally, drug sensitivity analysis, mRNA-miRNA network construction and single-cell transcriptome data analysis were performed. The experimental results showed that we screened 31 differentially expressed genes related to inflammatory response. Signaling pathways such as cytokine activity were associated with these genes. Three biomarkers were identified using machine learning algorithms: IL18R1, NMUR1 and RELA. Seventeen co-associated miRNAs were identified by the mRNA-miRNA network as possible regulatory nodes in PD. Finally, these three biomarkers were found to be closely associated with T cells, Endothelial cells, excitatory neurons, inhibitory neurons, and other cells in single-cell transcriptomic analysis. In conclusion, IL18R1, NMUR1 and RELA could be potential therapeutic targets for PD in inflammatory response and new biomarkers for PD diagnosis.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.